The differential prognostic implications of PD-L1 expression in the outcomes of Filipinos with EGFR -mutant NSCLC treated with tyrosine kinase inhibitors.

Herdee Gloriane C Luna, Marcelo Severino Imasa,Necy Juat,Katherine V Hernandez,Treah May Sayo,Gloria Cristal-Luna,Sheena Marie Asur-Galang,Mirasol Bellengan,Kent John Duga,Bien Brian Buenaobra,Marvin I De Los Santos,Daniel Medina,Jamirah Samo,Venus Minerva Literal,Neil Andrew Bascos, Sullian Sy-Naval

Translational lung cancer research（2023）

引用 0|浏览2

暂无评分

摘要

PD-L1 differentially influenced the outcomes of Filipinos with EGFR-mutant NSCLC. NSCLC subtypes, disease stage, and PD-1 expression may impact the collective outcomes associated with PD-L1 and EGFR-sensitizing mutations.

查看译文

关键词

Programmed death ligand-1 (PD-L1), non-small cell lung cancer (NSCLC), epidermal growth factor receptor mutations (EGFR mutations), Filipinos NSCLC, EGFR tyrosine kinase inhibitor (EGFR-TKI)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要